Stock listing
Alx Oncology Holdings Inc.
Selected listing: ALXO · BOATS · USD · US
Alx Oncology Holdings Inc. (BOATS:ALXO), Health Technology. Latest release Sep 28, 2026: ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase…
- Ticker
- BOATS:ALXO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Alx Oncology Holdings Inc.
Alx Oncology Holdings Inc. is a public company traded under the ticker ALXO in the American market. Alx Oncology focuses on developing innovative therapies for cancer treatment.
Latest news from Alx Oncology Holdings Inc.
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
September 28, 2026
ALX Oncology to Present at Upcoming Investor Conferences in September
September 2, 2026
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
June 30, 2026
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
June 1, 2026
Events
Research Alx Oncology Holdings Inc.
Alx Oncology Holdings Inc. company profile
View the public company page for Alx Oncology Holdings Inc. on 6ix.
Alx Oncology Holdings Inc. news
Read company news and market updates connected to Alx Oncology Holdings Inc..
Alx Oncology Holdings Inc. investor events
Find investor webinars, events, and replay context for Alx Oncology Holdings Inc..